gene silencing

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has signed a supply and distribution agreement enabling it to offer its customers access to Sirion Biotech's RNAiONE custom short hairpin RNA development services.

Dicerna Pharmaceuticals announced this week that it has taken a non-exclusive license to RNAi intellectual property held by Plant Bioscience Limited.

A study published in Nature Genetics last month has identified a genetic variant strongly associated with higher risk of certain brain tumors, and suggests the involvement of a long non-coding RNA or a microRNA.

Alnylam Pharmaceuticals this week announced that it has taken a non-exclusive license to RNAi-related intellectual property held by UK technology management firm Plant Bioscience Limited.

The company has added respiratory and inflammation to an RNAi screening program that began with oncology.

Papers of Note

Premium

RNAi-Related Papers Published April 2009

People in the News

Premium

Richard Chin, John Rossi, Alice Lin-Tsing, Kenneth Reed

Funding Update

Premium

NSF Microarray Grants Awarded Jan. 1 — March 31

Strands

Premium

Tekmira Pharmaceuticals, MDRNA

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.